Epigenetics Market
Report ID: SQMIG35H2201
Report ID: SQMIG35H2201
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2201 |
Region:
Global |
Published Date: February, 2025
Pages:
157
|Tables:
96
|Figures:
76
Epigenetics Market size was valued at USD 1.84 Billion in 2024 and is poised to grow from USD 2.11 Billion in 2025 to USD 6.36 Billion by 2033, growing at a CAGR of 14.8% during the forecast period (2026–2033).
The growth can be attributed to the important role in understanding gene regulation beyond DNA sequencing, aiding in disease research, and improving personalized medicine. Rising investments and finance are expected to boost the growth of the industry during the forecast period.
The prevalence of cancer across the globe is one of the major factors slowing the growth of the market in recent times. For example, according to the PAHO, there are an estimated 20 million new cases of cancer and 10 million deaths from cancer in 2023, and the number of reported cases of cancer each year is expected to be 30 million in the year 2040. Inhibitors of enzymes such as HDM, HMT, DNMT, HAT, and HDAC are used in epigenetic disorders. Other treatments, such as immunotherapy or chemotherapy, can work well. In the future, epigenetic therapy could be considered as the most effective strategy for treating cancer and brain diseases. Thus, the market is expected to grow significantly during the forecast period with high prevalence of cancers along with epigenetics for cancer.
Market snapshot - 2026-2033
Global Market Size
USD 1.6 billion
Largest Segment
Reagent
Fastest Growth
Services
Growth Rate
14.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Epigenetics Market is segmented by Product, Technology, Technique, Application, End-use and region. Based on Product, the market is segmented into Kits & Reagents, Instruments, Enzymes and Services. Based on Technology, the market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large non-coding RNA, MicroRNA modification and Chromatin structures. Based on Technique, the market is segmented into NGS, PCR & QPCR, Mass Spectrometry, Sonication and Other Techniques. Based on Application, the market is segmented into Oncology and Non-oncology oncology. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The reagent segment dominated the market, accounting for 33.45% of the global revenue in 2023. This segment can be largely attributed to the widespread use of reagents in the study of epigenetic modifications. Reagents play an important role in the study and manipulation of epigenetic mechanisms, involving changes in gene expression without altering the underlying DNA structure. These reagents are important for understanding epigenetic regulation and are used in the potential of research & therapeutic applications. Also, various industry players are providing resources for epigenetics research and studies. For example, Promega Corporation offers kits and reagents for the analysis of DNA methylation, histone modifications, and RNA transcription to support the epigenetic research. Thus, availability of more reagents from key players is also expected to be an important factor for the growth of this segment.
The services segment is expected to follow the highest CAGR of 17.68% during the forecast period. Epigenetic services include a range of offerings including sequencing, analysis and consultation services. Epigenetic analysis includes sophisticated techniques such as ChIP-seq, bisulfite sequencing, and DNA methylation profiling. Many researchers and organizations rely on specialized services to accurately and efficiently perform these complex assessments. The development of high-throughput sequencing technologies and other advanced tools for ongoing epigenetic research requires the development of projects where these technologies can be used to obtain complete and reliable epigenomic data.
The oncology segment dominated the market with 69.06% revenue share in 2023. Demand for epigenetics arises from the close association between epigenetic modifications and cancer progression. Epigenetic modifications are important in tumor initiation, progression and metastasis which is examined. Targeting these alterations provides potential avenues for new cancer therapies, including precision therapy. Understanding epigenetic mechanisms in oncology holds promise for the development of new diagnostics and more effective, personalized cancer interventions, and drives demand in the field.
Non-oncology is the fastest growing segment in the market. The non-oncology segment is projected to have the fastest CAGR of 16.30% from 2024 to 2031, due to the growth & development of epigenetics market in non-oncology applications of aging, reproductive health, mental health, drug development, precision medicine, regenerative medicine, materials contributed by a combination of the environmental interventions, chronic inflammatory diseases, and geriatrics.
To get detailed segments analysis, Request a Free Sample Report
North America dominated the market, with a share of 38.19% in 2023. The region is growing due to public awareness, improved pharmaceutical facilities and huge investments in R&D. Besides, prevalent chronic diseases and heavy investments by market players in epigenetic research, making it a promising environment for further growth. The presence of major players such as; Elemental Biological Sciences, Inc.; Dovetail Genomics LLC.; Illumina, Inc.; And in the U.S. market, Promega Corporation is expected to support regional expansion. It is expected that the epigenetics market will surge during the forecast period as chronic diseases prevail and increased investment by market players in epigenetics fuels regional growth. For example, epigenetic editing consumes another genomic medicine company, Croma Medicine, Inc.; (Croma) face million invested in US$.
Asia Pacific's epigenetics market is expected to witness the fastest CAGR of 16.71% from 2024 to 2031. This growth of the regional market is expected to be driven by the increasing demand for genome editing technologies and the spread of genetic diseases and infections in countries many such as India and Australia. Also, for epigenetics products and services that attract investment and funding from domestic companies. For example, in August 2023, Epigenic Therapeutics of China raised $32 million in funding. The company develops next-generation gene therapy that uses epigenome design to treat common disorders. Thus, increased investment in such infrastructure is expected to boost regional expansion. The epigenetics market in China is expected to grow during the forecast period, owing to the well-established regulatory framework for the development and commercialization of epigenetically engineered organisms (GMOs).
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence of Cancer and Chronic Diseases
Rise of Personalized Medicine
High Cost of Epigenetic Research and Therapy
Limited Understanding and Technical Challenges
Request Free Customization of this report to help us to meet your business objectives.
The epigenetics market is characterized by a dynamic and competitive landscape, with a mix of established players and emerging biotech companies driving innovation and growth. Key market participants are increasingly focusing on research and development (R&D) to develop novel epigenetic therapies and diagnostics, capitalizing on the rising interest in personalized medicine and targeted therapies.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the epigenetics market is experiencing strong growth driven by the rising incidence of cancer and chronic diseases, as well as increasing focus on personalized medicine but the market faces challenges such as rising research costs and a lack of understanding of complex epigenetic mechanisms. As the field of epigenetics keeps adapting, it has amazing potential to transform healthcare by way of permitting extra focused and personalized remedies. Advances within the epigenetic modifying technology and massive use of epigenetic biomarkers for disease diagnosis represent key factors with a purpose to form the future of the market.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.84 Billion |
| Market size value in 2033 | USD 6.36 Billion |
| Growth Rate | 14.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Epigenetics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Epigenetics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Epigenetics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Epigenetics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
